NEWS

April 6, 2021

Cancer biotech ImmVirX taps Bell Potter for $20m pre-IPO

SYDNEY: The team behind ex-ASX listed biotech Viralytics – which was bought by ... read more

April 6, 2021

Castle Rock to be wound up as investors chase millions

SYDNEY: Administrators to the Castle Rock Ponzi scheme that devastated investors on Sydney’s ... read more

April 6, 2021

AMP advisers look to new boss to end fight

MELBOURNE: The appointment of Alexis George to replace Francesco De Ferrari as AMP ... read more

April 6, 2021

CSL gives up on plans to develop COVID treatment

SYDNEY: CSL has shelved plans to develop a coronavirus treatment using the plasma ... read more